Peritoneal Surface Malignancy

I. Introduction II.Principles of Management III. Current Methodologies for Delivery of Intraperitoneal Chemotherapy
IV. Clinical Results of Treatment V. Ethical Considerations in Clinical Studies with Peritoneal Surface Malignancy VI. References

VI. References

Gunderson LL., Sosin H: Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum: Clinicopathologic correlation and implications for adjuvant therapy. Cancer 34:1278-1292, 1974
Sugarbaker PH: Surgical management of locally recurrent and metastatic colorectal cancer. (In) Karakousis CP, Copeland EM and Bland QUI (eds); Atlas of Surgical Oncology. Saunders: Philadelphia pp 671-692, 1995
Sugarbaker PH, Hughes KA: Surgery for Colorectal Metastasis to Liver. (In) Wanebo H (ed); Colorectal Cancer Mosby-Year Book, Inc.: St. Louis, 405-413, 1993
Sugarbaker PH: Peritoneal Carcinomatosis: Principles of Management. Kluwer:Boston 1996
Sugarbaker PH: Peritoneal carcinomatosis from appendiceal cancer: A paradigm for treatment of abdomino-pelvic dissemination of gastrointestinal malignancy. Acta Chirurgica Austriaca 28:4-8, 1996
Sugarbaker PH: Peritonectomy procedures. (In) Sugarbaker PH (ed); Peritoneal Carcinomatosis: Principles of Management. Kluwer, Boston pp 235-262, 1996
Jacquet P, Vidal-Jove J, Zhu BW, Sugarbaker PH: Peritoneal carcinomatosis from intraabdominal malignancy: Natural history and new prospects for management. Acta Belgica Chirurgica 94:191-197, 1994
Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ Mullins RE, Hull WE, Oliff L, Schlag P: Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 50:5790-5794, 1990
Sugarbaker PH, Gianola FJ, Speyer JL, Wesley R, Barofsky I, Meyers CE: Prospective randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 98:414-421, 1985
Sugarbaker PH, Averbach AM, Chang D: Adjuvant perioperative intraperitoneal chemotherapy for resectable gastric cancer: A call for a multi-institutional randomized trial. (In) Siewert JR, Roder JD (eds); Progress in Gastric Cancer Research, Monduzzi Editore: Bologna pp 1399-1405, 1997
Yu W, Whang I, Shu I, Averbach A, Chang D, Sugarbaker PH: Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant for resectable gastric cancer. Ann Surg (in press)
Gough DB, Donahue JH, Schutt AJ, Ghonchoroff N, Goellner JR, Wilson TO, Naessens JM, O’Brien PC, van Heerden JA: Pseudomyxoma peritonei: Long-term survival with an aggressive regional approach. Ann Surg 219:112-119, 1994
Zoetmulder FAN, Sugarbaker PH: Patterns of failure after complete cytoreduction and early postoperative intraperitoneal chemotherapy. Eur J CA 32A(10):1727-1733, 1996
Jacquet P, Sugarbaker PH: Wound recurrence after laparoscopic colectomy for cancer: New rationale for intraoperative intraperitoneal chemotherapy. Surg Endosc 10:295-296, 1996
Sugarbaker PH et al: Management of pseudomyxoma peritonei of appendiceal origin. Adv Surg 30:233-280, 1997
Archer A, Sugarbaker PH, Jelinek, J: Radiology of peritoneal carcinomatosis. (In) Sugarbaker PH (ed); Peritoneal Carcinomatosis: Principles of Management. Kluwer, Boston pp 263-288, 1996
Jacquet P, Jelinek J, Sugarbaker PH: Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am College Surg 181(6):530-538, 1995
Steller EP: Comparison of four scoring methods for an intraperitoneal immunotherapy model. Enhancement and Abrogation: Modifications of Host Immune Influence IL-2 and LAK Cell Immunotherapy (Ph.D. Thesis). Erasmus University Rotterdam, November 1988
Gomez Portilla A, Sugarbaker PH, Chang D: Second-look surgery after cytoreductive and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: Analysis of prognostic features. World J Surg (in press)
Berthet B, Sugarbaker TA, Chang: Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. (submitted)
Sugarbaker PH, Schellinx MET, Chang D, Koslowe P, von Meyerfeldt M: Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 20:585-592, 1996
Murio EJ, Sugarbaker PH: Gastrointestinal fistula following cytoreductive procedures for peritoneal carcinomatosis: Incidence and outcome. J Exp Clin Cancer Res 12:153-158, 1993
Fernandez-Trio V, Sugarbaker PH: Diagnosis and management of postoperative gastrointestinal fistulas: A kinetic analysis. J Exp Clin Cancer Res 13:233-241,1994
Gilly FN, Sayag, AC, Carry PY, Braillon GG, James IM, Volloch AA, Panteix GG: Intraperitoneal chemo-hyperthermic (CHIP): A new therapy in the treatment of the peritoneal seedings. Int Surg 76:164-167, 1991
Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, Kiuchi S, Okui K, Miyoshi K, Arimizu N, Takamizawa H: Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 208(1):36-41, 1988
Link K, Hepp G, Staib L, Butzer U, Bohm W, Beger HG: Intraperitoneal regional chemotherapy (IPRC) with mitoxantrone (In) Sugarbaker PH (ed); Peritoneal Carcinomatosis: Drugs and Diseases. Kluwer:Boston 1996 pp 31-40
Yonemura Y et al: Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 119(4):437-444,1996
Fujimoto S et al: Positive results of combined therapy of surgery and intraperitoneal hyperthermia perfusion for far-advanced gastric cancer. Ann Surg 212(5):592-596, 1990
Averbach AM, Sugarbaker PH: Recurrent intraabdominal cancer with intestinal obstruction. Int Surg 80(2):141-146, 1995
Stephens AD, Sugarbaker PH: Morbidity and mortality of cytoreductive surgery and hyperthermic intraoperative chemotherapy with mitomycin C using the coliseum technique. Monduzzi Editore (in press)